NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
The investigation concerns whether LifeStance and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On October 19, 2023, during market hours, The Bear Cave released a report entitled “Problems at LifeStance Health (LFST)”. In this report, The Bear Cave stated that, through numerous Freedom of Information Act requests, it had uncovered “dozens of complaints concerning overbilling, fraudulent billing, and unfair and deceptive business practices.” Further, “[a]fter reviewing the evidence”, The Bear Cave stated that it “is left wondering whether LifeStance is a thriving therapy franchise or an illegal billing operation with therapy on the side.”
On this news, LifeStance’s stock price fell $0.54 per share, or 8.89%, to close at $5.53 per share on October 19, 2023.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:Robert S. Willoughby
Pomerantz LLP
[email protected]
888-476-6529 ext. 7980
SOURCE Pomerantz LLP